clonidine has been researched along with nitrendipine in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (25.00) | 18.7374 |
1990's | 5 (17.86) | 18.2507 |
2000's | 12 (42.86) | 29.6817 |
2010's | 4 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Blue, DR; Clarke, DE; Vimont, RL | 1 |
Biguad, M; Julou-Schaeffer, G; Parratt, JR; Stoclet, JC | 1 |
Grosser, KD; Späh, F | 1 |
Conen, D; Müller, J; Noll, G; Rüttimann, S; Schneider, K | 1 |
Bähr, M; Langewitz, W; Rüddel, H; Schächinger, H; Schmieder, RE; Schulte, W | 1 |
Bähr, M; Langewitz, W; Rüddel, H; Schmieder, RE; Schulte, W | 1 |
Kannan, MS; Seip, AE | 1 |
Langewitz, W; Rüddel, H; Schmieder, R; Schulte, W | 1 |
Nazzari, M; Scapellato, L; Stornello, M; Valvo, EV | 1 |
Gross, G; Hanft, G; Michel, MC | 1 |
Lasova, L; Mutafova-Yambolieva, V; Radomirov, R; Staneva-Stoytcheva, D | 1 |
Boyanova, E; Genkova-Papazova, M; Lazarova-Bakarova, M; Petkova, BP; Staneva-Stoytcheva, D | 1 |
Chao, HM; Chidlow, G; Melena, J; Osborne, NN; Wood, JP | 1 |
Stiefelhagen, P | 1 |
Abdullah, NA; Armenia, A; Helmi, A; Johns, EJ; Munavvar, AS | 1 |
Füessl, HS | 1 |
Abdullah, NA; Johns, EJ; Khan, MA; Sattar, MA | 1 |
Abdullah, NA; Armenia, A; Johns, EJ; Khan, MA; Sattar, MA | 1 |
6 trial(s) available for clonidine and nitrendipine
Article | Year |
---|---|
Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rate.
Topics: Administration, Sublingual; Adult; Aged; Blood Pressure; Clonidine; Drug Therapy, Combination; Emergencies; Female; Heart Rate; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Nifedipine; Nitrendipine | 1988 |
Short- and long-term cerebrovascular effects of nitrendipine in hypertensive patients.
Topics: Adult; Aged; Cerebrovascular Circulation; Chlorthalidone; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Time Factors | 1988 |
Efficacy of four antihypertensive drugs (clonidine, enalapril, nitrendipine, oxprenolol) on stress blood pressure.
Topics: Adult; Blood Pressure; Blood Pressure Determination; Clinical Trials as Topic; Clonidine; Enalapril; Exercise Test; Humans; Hypertension; Male; Monitoring, Physiologic; Nitrendipine; Oxprenolol; Stress, Physiological; Stress, Psychological | 1989 |
Disparities in blood pressure control under various antihypertensive regimens.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Clonidine; Enalapril; Exercise Test; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Nitrendipine; Oxprenolol | 1989 |
Impact of antihypertensive therapy on blood pressure reactivity during mental stress.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clonidine; Hemodynamics; Humans; Hypertension; Magnesium; Male; Middle Aged; Nitrendipine; Oxprenolol; Stress, Psychological | 1988 |
Humoral and hemodynamic effects of nitrendipine versus clonidine in patients with essential hypertension.
Topics: Blood Glucose; Clonidine; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Insulin; Male; Middle Aged; Nitrendipine; Random Allocation; Renin-Angiotensin System | 1986 |
22 other study(ies) available for clonidine and nitrendipine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidney.
Topics: Adrenergic alpha-Antagonists; Animals; Binding Sites; Calcium Channels; Clonidine; In Vitro Techniques; Kidney; Male; Nitrendipine; Norepinephrine; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Vasoconstriction | 1992 |
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Caffeine; Calcimycin; Calcium; Clonidine; Endothelium, Vascular; Endotoxins; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrendipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |
Mechanisms of alpha-adrenoceptor mediated contractions of rat mesenteric artery.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Clonidine; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Nitrendipine; Norepinephrine; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vasoconstriction; Verapamil | 1986 |
Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cadmium; Cadmium Chloride; Calcium; Chlorides; Clonidine; Epinephrine; Heart Ventricles; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Nitrendipine; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Stimulation, Chemical; Vas Deferens | 1994 |
Effects of subchronic exposure of rats to lead or zinc on alpha-adrenoceptor-mediated contractile responses in isolated vas deferens.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Clonidine; Electric Stimulation; In Vitro Techniques; Lead; Male; Muscle Contraction; Muscle, Smooth; Nitrendipine; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Sulfates; Vas Deferens; Verapamil; Yohimbine; Zinc Compounds; Zinc Sulfate | 1993 |
Effects of flunarizine and nitrendipine on electroconvulsive shock- and clonidine-induced amnesia.
Topics: Adrenergic alpha-Agonists; Animals; Avoidance Learning; Calcium Channel Blockers; Clonidine; Electroshock; Flunarizine; Male; Memory; Nitrendipine; Rats; Rats, Wistar | 1997 |
An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Batrachotoxins; Betaxolol; Calcium Channel Blockers; Cerebral Cortex; Chick Embryo; Clonidine; Fibroblast Growth Factor 2; Neuroprotective Agents; Neurotoxins; Nitrendipine; Rabbits; Rats; Rats, Wistar; Reactive Oxygen Species; Retina; RNA, Messenger; Saxitoxin; Sodium Channels | 2000 |
[When hypertension becomes an emergency case: lower the blood pressure, but slowly!].
Topics: Administration, Oral; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diagnosis, Differential; Dihydralazine; Emergencies; Hospitalization; Humans; Hypertension; Hypertension, Malignant; Injections, Intravenous; Nifedipine; Nitrendipine; Nitroglycerin; Piperazines; Time Factors; Vasodilator Agents | 2003 |
The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats.
Topics: Animals; Blood Glucose; Clonidine; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Electric Stimulation; Infusions, Intravenous; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Kidney Cortex; Malaysia; Male; Methoxamine; Muscle, Smooth, Vascular; Nitrendipine; Norepinephrine; Phenylephrine; Piperazines; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Streptozocin; Time Factors; Vasoconstriction | 2004 |
[Emergency checklist in hypertensive crisis].
Topics: Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Clonidine; Diuretics; Emergencies; Female; Furosemide; Hospitalization; Humans; Hypertension; Male; Medical History Taking; Nifedipine; Nitrendipine; Pregnancy; Vasodilator Agents | 2006 |
Alpha1A- and alpha1D-adrenoceptors are the major functional subtypes of renal alpha1-adrenoceptors in streptozotocin-induced diabetic and normal Sprague-Dawley rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation; Kidney; Male; Methoxamine; Nitrendipine; Norepinephrine; Phenylephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Renal Artery; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Functional subtypes of renal alpha1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Clonidine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension, Renovascular; Kidney; Male; Methoxamine; Nitrendipine; Norepinephrine; Phenylephrine; Piperazines; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2008 |